It’s possible the licensing agreement RCRT executed with GOLQ holds high revenue potential since RCRT only had to pay them 16.66% of RCRT O/S and an 8% royalty fee on product licensing revenues.
According to their June 26, 2023 Video presentation they had some sort of AI breakthrough presumably via Radix AI. This is from the video transcript… Gologiq BOD Brent Suen stated:
“Our tech team came to me and my COO and said we've actually just had a massive breakthrough that was, believe it or not, in April of this year, right before we were introduced to Miles and Evan and the team at RCRT. So it could not have been more timely. This breakthrough, by the way, generated 3 million in revenues on a pilot program the first month out with our partner, and this evidence points us towards a $70 million year, one run rate and profitability within three months.
So coming in as we are into RCRT right
now on the heels of this breakthrough, we think is extremely timely and extremely compelling to you all as shareholders of RCRT and subsequently GoLogiq.
——————————-
If RCRT using affiliates (CognoGroup) to license the products at an initial annual run rate of $70M - 8% to $GOLQ = $64.4M run rate.
Say RCRT splits that with $AESO 50/50, that ends up $32.2M annually just from the licensing agreement.
Seems far fetched, but is it? Radix is AI. Combine this with the other $RCRT spinout assets and could be $40M per year for the first few years as they scale and refine the products (development was as stated part of the licensing agreement).
This is all IMO, I do still think GOLQ eventually ends up in the Naz shell, which is why they listed the products could be bought for only $400K. Super cheap for tools that can supposedly generate $70 annually.
$AESO
